| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |